𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose chemotherapy and autologous transplantation for non-Hodgkin’s lymphoma

✍ Scribed by Julie M. Vose

Publisher
Carden Jennings Publishing
Year
2002
Tongue
English
Weight
389 KB
Volume
76
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Consolidative involved field radiotherap
Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study
✍ Christoph Oehler-Jänne; Christian Taverna; Nadine Stanek; Laura Negretti; Urs M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract The role of involved field radiation therapy (IF‐RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non‐Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IF‐RT. A

Non-Hodgkin's lymphoma after liver trans
Non-Hodgkin's lymphoma after liver transplantation: Response to chemotherapy
✍ Gallego-Melcón, Soledad; Sánchez de Toledo, José; Martínez, Vicente; Moraga, Fer 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

An increased incidence of lymphoproliferative disorders in immunosuppressed organ transplant recipients has long been recognised. Lymphoproliferative disorders occur in 2% of orthotopic liver transplant patients. Different therapies have been used, but the optimal treatment remains unknown. Relative